X0303 4 2008-08-20 1 0001125603 SGX PHARMACEUTICALS, INC. SGXP 0001242880 HENNEY CHRISTOPHER S 10505 ROSELLE STREET SAN DIEGO CA 92121 1 0 0 0 Common Stock 2008-08-20 4 D 0 97165 3 D 0 D Non-Qualified Stock Option (right to buy) 1.35 2008-08-20 4 D 0 20000 1.65 D 2018-06-04 Common Stock 20000 0 D Non-Qualified Stock Option (right to buy) 5.03 2008-08-20 4 D 0 25000 0 D 2017-05-16 Common Stock 25000 0 D Non-Qualified Stock Option (right to buy) 5.21 2008-08-20 4 D 0 30000 0 D 2017-06-07 Common Stock 30000 0 D Disposed of pursuant to The Agreement and Plan of Merger dated July 8, 2008 by and among the issuer, Eli Lilly and Company and REM Merger Sub, Inc. (the "Merger Agreement"). Disposed of pursuant to the Merger Agreement dated July 8, 2008 in exchange for $3.00 for each share of SGX Pharmaceuticals, Inc. common stock held by the reporting person. The vesting for this option was accelerated and the option cancelled as of August 20, 2008 pursuant to the Merger Agreement in exchange for a cash payment equal to the product of (i) the number of shares of SGX Pharmaceuticals, Inc. common stock subject to the option multiplied by (ii) the excess of $3.00 over the per share exercise price. The vesting for this option was accelerated and the option cancelled as of August 20, 2008 pursuant to the Merger Agreement. No cash payment was made in exchange. By: Annette C. North, as attorney-in-fact For: Christopher Henney 2008-08-21